HARVEY BARTLE, III, District Judge.
AND NOW, this 25th day of August, 2016, following
(1) the motions of plaintiff Federal Trade Commission to compel defendants AbbVie Inc., Abbott Laboratories, and Unimed Pharmaceuticals LLC to produce documents (Docs. # 190 and 192) are GRANTED in part and DENIED in part;
(2) the defendants shall produce forthwith the following challenged documents from the Pennsylvania privilege log as they are not protected by the attorney-client privilege or work product doctrine: 98, 538, 539, 600, 656, 711, 724, 726, 727, 839, 921, 1071, 1178, 1259, 1260, 1261, 1309, 1445, 1452, 1482, 1485, 1487, 1494, 1513, 1732, 1739, 2103, 2412, 2488, and 2489;
(3) the defendants shall produce forthwith the following challenged documents from the Georgia privilege log as they are not protected by the attorney-client privilege or work product doctrine: 972, 973, 1033, 1058, 1321, 2913, 2919, 2920, 2921, 2922, 2926, 2932, 2933, 2934, 2967, 2974, 2981, 2982, 2987, 2989, 2995, 3001, 3002, 3040, 3041, 3101, 3379, 4605, 5032, the redacted text under item "4" in 6984, 8230, 8258, 8274, 8344, 8347, and 8679; and
(4) the motions of the plaintiff to compel the defendants to produce documents are otherwise DENIED.